Loading the section
IMCB PJSC (GEMA): the company is profitable, net margin 42.0%; profit is backed by cash, cash flow to profit 1.29×. Dividends are sustainable. Data as of 28 September 2026.
Answers to 3 of 4 questions
What share of revenue the company keeps as profit
Data as of 5 October 2026
Does the company pay dividends regularly and can it afford the payout
Data as of 28 September 2026
Is the company's profit backed by real cash
Data as of 5 October 2026
P/E · RAS · Price as of 24 March 2026
Based on the 2025 annual report, P/E is 11.17×. In earlier years it ranged from 8.84× to 21.24×, with a median of 13.31×; observations: 5. That is below its own median.
By report year
P/E
Observations with a similar valuation: 2 — too few to speak of a pattern.
A similar valuation means P/E within a quarter of the current value. Each year's price is taken the following spring, once the annual report is known; the price change runs between those dates of adjacent years and excludes dividends. The share count used is the current one. This describes the past and is not a forecast.
Dividends are sustainable. The last payout was RUB 2.74 per share.
The company is profitable, net margin 42.0%. Net income is RUB 158.39 m.
Based on the 2025 annual report, P/E is 11.17×. In earlier years it ranged from 8.84× to 21.24×, with a median of 13.31×; observations: 5. That is below its own median.
There is no forecast here: this page does not predict the price. It shows what happened after a similar valuation in the past. Observations with a similar valuation: 2 — too few to speak of a pattern. A similar valuation means P/E within a quarter of the current value. Each year's price is taken the following spring, once the annual report is known; the price change runs between those dates of adjacent years and excludes dividends. The share count used is the current one. This describes the past and is not a forecast.
The company's statements do not hold enough data for these questions yet:
What date the figures on this page are as of
The analysis is built on the issuer's published financial statements and disclosures. It is information, not investment advice.